Zhenzhong Li

Title: Zhenzhong Li: Innovator in Oncology

Introduction

Zhenzhong Li is a notable inventor based in Tianjin, China. He has made significant contributions to the field of oncology through his innovative research and development of pharmaceutical compounds. With a focus on anticancer therapies, his work has garnered attention in the scientific community.

Latest Patents

Zhenzhong Li holds 2 patents, including his latest work on tetracyclic anthraquinone derivatives. This patent discloses a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. The invention includes a method for treating cancer, which involves administering a therapeutically effective amount of the compound to a subject in need. The compound exhibits good anticancer and/or antitumor activity, along with favorable water solubility and stability, making it a promising candidate for cancer treatment. Additionally, the patent outlines a process for preparing the compound, further emphasizing its potential in therapeutic applications.

Career Highlights

Throughout his career, Zhenzhong Li has worked with various companies, including Tianjin Hemay Oncology Pharmaceutical Co., Ltd. and Tianjin Hemay Bio-tech Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of effective cancer treatments.

Collaborations

Zhenzhong Li has collaborated with notable colleagues, including Hesheng Zhang and Aihong Huo. These partnerships have facilitated the exchange of ideas and expertise, enhancing the quality of his research and innovations.

Conclusion

Zhenzhong Li's contributions to oncology through his patents and collaborations highlight his commitment to advancing cancer treatment. His innovative work continues to inspire and pave the way for future developments in the field.